Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 7:39 pm |
N/A 2029-06-10 |
Equillium Inc. | EQ | Pruzanski Mark Director |
76,770 | $0 | 76,770 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-23 6:02 pm |
N/A 2034-05-22 |
Equillium Inc. | EQ | Pruzanski Mark Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:40 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
618,894 | $19 | 0 (Direct) |
View |
| 2023-05-22 Option Award |
2023-05-23 6:04 pm |
N/A 2033-05-22 |
Equillium Inc. | EQ | Pruzanski Mark Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-25 7:54 pm |
N/A 2032-05-24 |
Equillium Inc. | EQ | Pruzanski Mark Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 4:05 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,138 | $17.21 | 618,894 (Direct) |
View |
| 2021-11-30 Tax Withholding |
2021-12-02 4:05 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
3,817 | $17.21 | 618,894 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-02 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,138 | $16.86 | 616,573 (Direct) |
View |
| 2021-10-29 Tax Withholding |
2021-11-02 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
3,817 | $16.86 | 616,573 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-04 5:02 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
3,816 | $14.85 | 614,252 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 5:02 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,136 | $14.85 | 614,252 (Direct) |
View |
| 2021-08-31 Option Award |
2021-09-01 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,138 | $14.91 | 611,932 (Direct) |
View |
| 2021-08-31 Tax Withholding |
2021-09-01 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
3,817 | $14.91 | 611,932 (Direct) |
View |
| 2021-07-30 Tax Withholding |
2021-08-02 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
3,817 | $17.28 | 609,611 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-02 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,138 | $17.28 | 609,611 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-01 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
3,816 | $19.97 | 607,290 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-01 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,136 | $19.97 | 607,290 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-02 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,138 | $16.63 | 604,970 (Direct) |
View |
| 2021-05-28 Tax Withholding |
2021-06-02 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
3,817 | $16.63 | 604,970 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:18 pm |
N/A 2031-05-26 |
Equillium Inc. | EQ | Pruzanski Mark Director |
20,770 | $0 | 20,770 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-04 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,138 | $19.78 | 602,649 (Direct) |
View |
| 2021-04-30 Tax Withholding |
2021-05-04 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
3,817 | $19.78 | 602,649 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-01 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,136 | $23.08 | 600,328 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-01 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
3,658 | $23.08 | 600,328 (Direct) |
View |
| 2021-02-26 Tax Withholding |
2021-03-02 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
2,741 | $21.66 | 597,850 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,138 | $21.66 | 597,850 (Direct) |
View |
| 2021-01-29 Tax Withholding |
2021-02-02 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
2,741 | $35.24 | 594,453 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
6,138 | $35.24 | 594,453 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
41,236 | $24.7 | 591,056 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
25,697 | $24.7 | 591,056 (Direct) |
View |
| 2020-10-01 Tax Withholding |
2020-10-05 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark President & CEO |
772 | $42.08 | 575,517 (Direct) |
View |
| 2020-07-01 Tax Withholding |
2020-07-06 7:02 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark President & CEO |
772 | $46.52 | 576,289 (Direct) |
View |
| 2020-05-19 Option Award |
2020-05-21 4:30 pm |
N/A 2030-05-19 |
Equillium Inc. | EQ | Pruzanski Mark Director |
24,000 | $0 | 24,000 (Direct) |
View |